IO Biotech's total assets for Q3 2024 were $89.94M, a decrease of -19.31% from the previous quarter. IOBT total liabilities were $17.38M for the fiscal quarter, a 14.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.